1-8 of 8
Keywords: Safety
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Subject Area:
Nephrology
Am J Nephrol (2021) 52 (10-11): 871–883.
Published Online: 16 September 2021
... for the treatment of anemia associated with chronic kidney disease (CKD) in the “Molidustat Once Daily Improves Renal Anemia by Inducing EPO” (MIYABI) program, which comprises 5 phase 3 clinical trials. The present MIYABI Non-Dialysis Correction (ND-C) study investigated the efficacy and safety of molidustat...
Journal Articles
Subject Area:
Nephrology
Am J Nephrol (2021) 52 (3): 199–208.
Published Online: 31 March 2021
...) and a 10% decrease in the risk of bleeding outcomes (HR 0.90, 95% CI: 0.88–0.92, p < 0.001) compared to warfarin after adjustment. On stratified analyses, DOACs maintained a superior safety profile across CKD stages. Patients with AF on DOACs had a consistently lower risk of cardiovascular and bleeding...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Nephrology
Am J Nephrol (2012) 35 (4): 321–326.
Published Online: 24 March 2012
... and assessed its safety and efficacy. Methods: Patients with an SBP <140 mm Hg and a BMI ≤35 who were not taking anticoagulants, ASA and NSAIDS in the preceding week were included. Biopsies were performed under ultrasound guidance using a 15-gauge needle that changed to a 14-gauge needle during the study...